O	0	10	Evaluation
O	11	13	of
O	14	26	telemedicine
O	27	30	for
O	31	40	screening
O	41	43	of
B-Disease	44	52	diabetic
I-Disease	53	64	retinopathy
O	65	67	in
O	68	71	the
O	72	80	Veterans
O	81	87	Health
O	88	102	Administration
O	102	103	.

O	105	107	To
O	108	115	explore
O	116	119	the
O	120	124	cost
O	124	125	-
O	125	138	effectiveness
O	139	141	of
O	142	154	telemedicine
O	155	158	for
O	159	162	the
O	163	172	screening
O	173	175	of
B-Disease	176	184	diabetic
I-Disease	185	196	retinopathy
O	197	198	(
B-Disease	198	200	DR
O	200	201	)
O	202	205	and
O	206	214	identify
O	215	222	changes
O	223	229	within
O	230	233	the
O	234	246	demographics
O	247	249	of
O	250	251	a
O	252	259	patient
O	260	270	population
O	271	276	after
O	277	289	telemedicine
O	290	304	implementation
O	304	305	.

O	306	307	A
O	308	321	retrospective
O	322	329	medical
O	330	335	chart
O	336	342	review
O	343	344	(
O	344	350	cohort
O	351	356	study
O	356	357	)
O	358	361	was
O	362	371	conducted
O	371	372	.

O	373	374	A
O	375	380	total
O	381	383	of
O	384	387	900
B-Disease	388	392	type
I-Disease	393	394	1
I-Disease	395	398	and
I-Disease	399	403	type
I-Disease	404	405	2
I-Disease	406	414	diabetic
O	415	423	patients
O	424	432	enrolled
O	433	435	in
O	436	437	a
O	438	445	medical
O	446	452	system
O	453	457	with
O	458	459	a
O	460	472	telemedicine
O	473	482	screening
O	483	490	program
O	491	494	for
B-Disease	495	497	DR
O	497	498	.

O	499	502	The
O	503	507	cost
O	507	508	-
O	508	521	effectiveness
O	522	524	of
O	525	528	the
B-Disease	529	531	DR
O	532	544	telemedicine
O	545	552	program
O	553	556	was
O	557	567	determined
O	568	570	by
O	571	576	using
O	577	578	a
O	579	585	finite
O	585	586	-
O	586	593	horizon
O	593	594	,
O	595	603	discrete
O	604	608	time
O	608	609	,
O	610	620	discounted
B-Diagnostic_tool	621	627	Markov
I-Diagnostic_tool	628	636	decision
I-Diagnostic_tool	637	644	process
I-Diagnostic_tool	645	650	model
O	651	660	populated
O	661	663	by
O	664	674	parameters
O	675	678	and
O	679	686	testing
O	687	696	frequency
O	697	705	obtained
O	706	710	from
O	711	718	patient
O	719	726	records
O	726	727	.

O	728	731	The
O	732	737	model
O	738	747	estimated
O	748	751	the
O	752	763	progression
O	764	766	of
B-Disease	767	769	DR
O	770	773	and
O	774	784	determined
B-Characteristic	785	792	average
I-Characteristic	793	800	quality
I-Characteristic	800	801	-
I-Characteristic	801	809	adjusted
I-Characteristic	810	814	life
I-Characteristic	815	820	years
O	821	822	(
B-Characteristic	822	827	QALYs
O	827	828	)
O	829	834	saved
O	835	838	and
O	839	846	average
O	847	857	additional
O	858	862	cost
O	863	871	incurred
O	872	874	by
O	875	878	the
O	879	891	telemedicine
O	892	901	screening
O	902	909	program
O	909	910	.

B-Disease	911	919	Diabetic
I-Disease	920	931	retinopathy
O	931	932	,
B-Disease	933	940	macular
I-Disease	941	946	edema
O	946	947	,
B-Disease	948	957	blindness
O	957	958	,
O	959	962	and
O	963	973	associated
B-Characteristic	974	979	QALYs
O	979	980	.

O	981	984	The
O	985	992	results
O	993	1001	indicate
O	1002	1006	that
O	1007	1019	telemedicine
O	1020	1029	screening
O	1030	1032	is
O	1033	1037	cost
O	1037	1038	-
O	1038	1047	effective
O	1048	1051	for
B-Disease	1052	1054	DR
O	1055	1060	under
O	1061	1065	most
O	1066	1076	conditions
O	1076	1077	.

O	1078	1080	On
O	1081	1088	average
O	1088	1089	,
O	1090	1092	it
O	1093	1095	is
O	1096	1100	cost
O	1100	1101	-
O	1101	1110	effective
O	1111	1114	for
O	1115	1122	patient
O	1123	1134	populations
O	1135	1137	of
O	1139	1140	>
O	1141	1145	3500
O	1145	1146	,
B-Characteristic	1147	1155	patients
I-Characteristic	1156	1160	aged
I-Characteristic	1162	1163	<
I-Characteristic	1164	1166	80
I-Characteristic	1167	1172	years
O	1172	1173	,
O	1174	1177	and
O	1178	1181	all
O	1182	1188	racial
O	1189	1195	groups
O	1195	1196	.

O	1197	1207	Observable
O	1208	1214	trends
O	1215	1219	were
O	1220	1230	identified
O	1231	1233	in
O	1234	1237	the
O	1238	1247	screening
O	1248	1258	population
O	1259	1264	since
O	1265	1268	the
O	1269	1283	implementation
O	1284	1286	of
O	1287	1299	telemedicine
O	1300	1309	screening
O	1309	1310	:
O	1311	1314	the
O	1315	1321	number
O	1322	1324	of
O	1325	1330	known
B-Disease	1331	1333	DR
O	1334	1339	cases
O	1340	1343	has
O	1344	1353	increased
O	1353	1354	,
O	1355	1358	the
O	1359	1366	overall
O	1367	1370	age
O	1371	1373	of
O	1374	1382	patients
O	1383	1392	receiving
O	1393	1403	screenings
O	1404	1407	has
O	1408	1417	decreased
O	1417	1418	,
O	1419	1422	the
O	1423	1433	percentage
O	1434	1436	of
B-Characteristic	1437	1446	nonwhites
O	1447	1456	receiving
O	1457	1467	screenings
O	1468	1471	has
O	1472	1481	increased
O	1481	1482	,
O	1483	1486	the
O	1487	1494	average
O	1495	1501	number
O	1502	1504	of
O	1505	1510	miles
O	1511	1519	traveled
O	1520	1522	by
O	1523	1524	a
O	1525	1532	patient
O	1533	1535	to
O	1536	1543	receive
O	1544	1545	a
O	1546	1555	screening
O	1556	1559	has
O	1560	1569	decreased
O	1569	1570	,
O	1571	1574	and
O	1575	1578	the
O	1579	1590	teleretinal
O	1591	1600	screening
O	1601	1614	participation
O	1615	1617	is
O	1618	1628	increasing
O	1628	1629	.

O	1630	1633	The
O	1634	1641	current
B-Diagnostic_tool	1642	1653	teleretinal
I-Diagnostic_tool	1654	1663	screening
I-Diagnostic_tool	1664	1671	program
O	1672	1674	is
O	1675	1684	effective
O	1685	1687	in
O	1688	1693	terms
O	1694	1696	of
O	1697	1702	being
O	1703	1707	cost
O	1707	1708	-
O	1708	1717	effective
O	1718	1721	and
O	1722	1732	increasing
O	1733	1743	population
O	1744	1749	reach
O	1749	1750	.

O	1751	1757	Future
O	1758	1767	screening
O	1768	1776	policies
O	1777	1783	should
O	1784	1788	give
O	1789	1802	consideration
O	1803	1805	to
O	1806	1809	the
O	1810	1813	age
O	1814	1816	of
O	1817	1825	patients
O	1826	1835	receiving
O	1836	1846	screenings
O	1847	1850	and
O	1851	1854	the
O	1855	1861	system
O	1861	1862	'
O	1862	1863	s
O	1864	1871	patient
O	1872	1876	pool
O	1877	1881	size
O	1882	1889	because
O	1890	1893	our
O	1894	1901	results
O	1902	1910	indicate
O	1911	1913	it
O	1914	1916	is
O	1917	1920	not
O	1921	1925	cost
O	1925	1926	-
O	1926	1935	effective
O	1936	1938	to
O	1939	1945	screen
O	1946	1954	patients
B-Characteristic	1955	1959	aged
I-Characteristic	1960	1965	older
I-Characteristic	1966	1970	than
I-Characteristic	1971	1973	80
I-Characteristic	1974	1979	years
O	1980	1982	or
O	1983	1985	in
O	1986	1997	populations
O	1998	2002	with
O	2004	2005	<
O	2006	2010	3500
O	2011	2019	patients
O	2019	2020	.
